• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
195.45
  -2.66  
- 1.34%
1,095,667,000
242.37
145.12

Insider Trade Data

Date Insider Shares Type Value
09/01/2015 Walt, David R 2,000 Sell $390,151
08/27/2015 Dadswell, Charles E 163 Sell $32,406
08/27/2015 Flatley, Jay T 25,000 Sell $5,004,125
08/27/2015 Flatley, Jay T 25,000 Exchange $699,250
08/18/2015 Walt, David R 7,497 Sell $1,560,972

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
NAICS - 541711 - Research and Development in Biotechnology
Subscribe Today!